The MSDx Opportunity: A Disease without a blood test

Multiple Sclerosis Diagnostics LLC (MSDx) is focused on commercializing In Vitro Diagnostic (IVD) blood test products for MS. The company discovered a novel source of biomarkers that reflect the disease activity of a Multiple Sclerosis (MS) patient. These biomarkers provide meaningful information that aid in monitoring disease progression and response to drug therapy, predict an impending relapse, and facilitate drug development. MSDx is developing this patent pending technology into simple blood test products that will be sold to research and clinical laboratories around the world. MSDx is focused on building the best diagnostic channel for selling proprietary and licensed test kits into the Multiple Sclerosis market.